Predicted to enable AMP deaminase activity. Predicted to be involved in AMP metabolic process and IMP biosynthetic process. Predicted to be located in cytosol. Human ortholog(s) of this gene implicated in several diseases, including congestive heart failure; hereditary spastic paraplegia 63; and pontocerebellar hypoplasia type 9. Is an ortholog of human AMPD2 (adenosine monophosphate deaminase 2).
Map position created from combination of previous interpolated map position (based on known location of sequence) and allele information. Therefore this is not a genetic map position based on recombination frequencies or genetic experiments. This was done on advice of the CGC.